Ultragenyx Pharmaceutical Inc. (RARE) declined -5.35% or -2.79 to $49.41. It is approximately 439434 shares traded, which is 84.48% compare to the average total volume 520182. The market cap of RARE is $2.45 billion. The year to date change is 5.9%. The 52 week price range is from $41.67 to $71.99. Price of RARE have changed 2.61% during last week. It have changed 4.55% over last month, 8.05% over last 3 months, -0.17% over last 6 months and -25.41% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RARE is 50.51. It is 2.23% above current price. The 200-day Moving Averages for RARE is 53.69. It is 8.66% above current price. The 52-week High is 71.99. It is 45.70% from the current price. The 52-week Low is 41.67. It is -15.66% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RARE is 8.26 on 2018-02-28. Short % to float is 9.79%. There are some statistics of RARE. It is has market cap $2.45 billion. The share outstanding is 49.61 million. The average volume is 520182. The revenue is 2.61M. The gross profit is 2.41M. The percent of top 15 Institution holding is 73.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RARE is -65.39%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RARE is -54.56%.